HPHA — Heidelberg Pharma AG Share News
0.000.00%
Last trade - 00:00- €120.70m
- €147.30m
- €1.46m
Brief: Heidelberg Pharma H1 Revenues At EUR 3.1 Mln
Brief: Heidelberg Pharma Raises EUR 14.4 Mln From Private Placement
Brief: Heidelberg Pharma Plans Capital Increase Of Up To 10%
Brief: Heidelberg Pharma Q1 Net Loss Widens To EUR 4.6 Million
Brief: Heidelberg Pharma FY Sales Revenue At EUR 7.3 Mln
Brief: Heidelberg Pharma Wins U.S. Patent Rights For TP53/RNA Polymerase II Deletion Treatment
Brief: Heidelberg Pharma Secures Financing From Main Shareholder Dievini
Brief: Heidelberg Pharma Participates In Franco-German Joint Venture
Brief: Heidelberg Pharma: Magenta Therapeutics To Further Develop Antibody Targeted Amanitin Conjugates
Brief: Heidelberg Pharma Requests Mandatory Conversion Of Notes Issued Nov 2017
Brief: Heidelberg Pharma Raises 2019 Guidance
Brief: Heidelberg Pharma Receives European Union Research Grant For ETN Magicbullet Project
Brief: Heidelberg Pharma H1 Net Loss Narrows To EUR 4.3 Mln
Brief: Heidelberg Pharma Receives Milestone Payment From Partner Telix
Brief: Heidelberg Pharma Q1 Group Net Loss Of EUR 3.1 Million
Brief: Heidelberg Pharma FY Sales Revenue Up By 93% To EUR 3.7 Mln
Brief: Heidelberg Pharma 9-month Sales Up 2 Pct To EUR 1.7 Billion
Brief: Heidelberg Pharma Receives Milestone Payment From Partner Link Health
Brief: Heidelberg Pharma: Partner Magenta Therapeutics Exercises Option To Further Develop Target Molecule